Table 2.
Study | n | Size | n | PC-RPLND | Viable cancer |
---|---|---|---|---|---|
Friedman et al. [1985] | 15 | ≥ 3 cm/< 3 cm | 11/4 | 3/0 | 0 |
Schultz et al. [1989] | 21 | ≥ 3 cm/< 3 cm | 9/12 | 1/2 | 0 |
Fosså et al. [1987] | 16 | ≥ 3 cm/< 3 cm | 10/6 | 3/1 | 0 |
Ravi et al. [1994] | 43 | ≥ 3 cm/< 3 cm | 25/18 | 15/4 | 3/0 |
Puc et al. [1996] | 104 | ≥ 3 cm/< 3 cm | 30/74 | 27/28 | 6/0 |
Flechon et al. [1979] | 60 | ≥ 3 cm/< 3 cm | 31/29 | 15/12 | 2/0 |
Total | 259 | ≥ 3 cm/< 3 cm | 116/143 | 64/47 | 11(17%)/0 |
PC-RPLND, postchemotherapy retroperitoneal lymph node dissection